The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Audhya Paul K. since 2022.
This trader's CIK number is 1860131.
At the time of last reporting, Audhya Paul K. was the CHIEF MEDICAL OFFICER of Kalvista Pharmaceuticals, Inc.. (stock ticker symbol KALV).
Also see all insider trading activities at Kalvista Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | KALV | 0 | $0 | 16,264 | $196,854 | 35,590 | $0 |
| 2024 | KALV | 0 | $0 | 47,842 | $575,382 | 108,286 | $0 |
| 2023 | KALV | 0 | $0 | 22,197 | $206,089 | 49,952 | $0 |
| 2022 | KALV | 0 | $0 | 722 | $3,927 | 2,419 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-22 | KALV | Option Ex | 5,000 | .00 | 0 |
| 2025-08-25 | KALV | Sale | 2,336 | 13.42 | 31,349 |
| 2025-08-21 | KALV | Option Ex | 6,250 | .00 | 0 |
| 2025-08-22 | KALV | Sale | 2,942 | 13.22 | 38,902 |
| 2025-08-18 | KALV | Sale | 2,939 | 13.19 | 38,756 |
| 2025-08-17 | KALV | Option Ex | 6,446 | .00 | 0 |
| 2025-05-22 | KALV | Option Ex | 5,000 | .00 | 0 |
| 2025-05-23 | KALV | Sale | 2,146 | 11.31 | 24,271 |
| 2025-05-17 | KALV | Option Ex | 6,447 | .00 | 0 |
| 2025-05-19 | KALV | Sale | 2,776 | 11.84 | 32,876 |
| 2025-02-17 | KALV | Option Ex | 6,447 | .00 | 0 |
| 2025-02-18 | KALV | Sale | 3,125 | 9.82 | 30,700 |
| 2024-11-26 | KALV | Sale | 2,187 | 9.87 | 21,585 |
| 2024-11-22 | KALV | Option Ex | 5,000 | .00 | 0 |
| 2024-11-17 | KALV | Option Ex | 18,531 | .00 | 0 |
| 2024-11-18 | KALV | Sale | 8,077 | 9.26 | 74,768 |
| 2024-08-22 | KALV | Option Ex | 5,000 | .00 | 0 |
| 2024-08-23 | KALV | Sale | 2,135 | 12.40 | 26,474 |
| 2024-08-19 | KALV | Sale | 7,973 | 12.01 | 95,779 |
| 2024-08-17 | KALV | Option Ex | 18,528 | .00 | 0 |
| 2024-05-17 | KALV | Option Ex | 30,614 | .00 | 0 |
| 2024-05-20 | KALV | Sale | 13,175 | 11.77 | 155,003 |
| 2024-02-17 | KALV | Option Ex | 30,613 | .00 | 0 |
| 2024-02-20 | KALV | Sale | 14,295 | 14.12 | 201,773 |
| 2023-11-17 | KALV | Option Ex | 18,530 | .00 | 0 |
| 2023-11-20 | KALV | Sale | 7,985 | 8.23 | 65,708 |
| 2023-08-17 | KALV | Option Ex | 18,529 | .00 | 0 |
| 2023-08-18 | KALV | Sale | 8,020 | 10.73 | 86,046 |
| 2023-05-17 | KALV | Option Ex | 6,447 | .00 | 0 |
| 2023-05-18 | KALV | Sale | 2,780 | 10.14 | 28,200 |
| 2023-02-17 | KALV | Option Ex | 6,446 | .00 | 0 |
| 2023-02-17 | KALV | Sale | 3,412 | 7.66 | 26,135 |
| 2022-11-17 | KALV | Option Ex | 2,419 | .00 | 0 |
| 2022-11-18 | KALV | Sale | 722 | 5.44 | 3,927 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Audhya Paul K. (CHIEF MEDICAL OFFICER of Kalvista Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.